Markus Enzelberger und Chief Scientific Officer - Info zur Person

(1 - 29 von 48

)

DGAP-News: Markus Enzelberger, Chief Scientific Officer of

www.sharewise.com

Ağ20 Kas · DGAP-News: Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure

MorphoSys : Dr. Markus Enzelberger Appointed MorphoSys's …

uk.marketscreener.com

Ağ30 Eki · DGAP-News: MorphoSys AG / Key word: Change of Personnel/Miscellaneous Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer :30 …

Partners in immuno-oncology | Drug Discovery Newswww.drugdiscoverynews.com › partners-in-immuno-oncology

www.drugdiscoverynews.com

Markus Enzelberger, chief scientific officer of MorphoSys. “By addressing this target molecule, we seek to modulate the tumor microenvironment. We look ...

MorphoSys appoints chief scientific officer - S&P Globalwww.spglobal.com › news-insights › trending

www.spglobal.com

· Morphosys AG permanently appointed Markus Enzelberger to the position of chief scientific officer. Enzelberger has been the company's ...

MorphoSys Names Markus Enzelberger Interim CSO As Sproll ...markets.businessinsider.com › News › Stock News

markets.businessinsider.com

The Supervisory Board of MorphoSys has named Markus Enzelberger as Interim Chief Scientific Officer for the duration of Sproll's absence. Enzelberger currently ...

Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces...

markets.businessinsider.com

Markus Enzelberger, the company's Chief Scientific Officer (CSO), has decided to step down as CSO and member of the company's Management ...

LEO Pharma and MorphoSys Expand Strategic Alliance to Develop...

www.businesswire.com

... Pharma with the goal of developing novel, peptide-derived drugs,” said Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG.

Markus Enzelberger - Morphosys Insider Transactions - TipRanks.comwww.tipranks.com › ... › Insiders

www.tipranks.com

Markus Enzelberger, Chief Scientific Officer at Morphosys (GB:0NDV), has a % success rate when buying and selling stocks.

MorphoSys to Present at Upcoming Investor Conferenceswww.1stoncology.com › blog › morphosys-to-prese...

www.1stoncology.com

· Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG. Investor & Analyst Event Date: December 5, Venue: New York, NY, U.S.

Markus Enzelberger, Chief Scientific Officer of Yahoo Financefinance.yahoo.com › news › markus-enzelberger-ch...

finance.yahoo.com

· Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure · PLANEGG/MUNICH, GERMANY / ACCESSWIRE / November 20,

Markus Enzelberger, Chief Scientific Officer of BioSpacewww.biospace.com › article › markus-enzelberger-c...

www.biospace.com

· Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure - read this article along with other careers information, ...

MOR106 clinical development in atopic dermatitis stopped for futilitykommunikasjon.ntb.no › pressemelding › mor106-c...

kommunikasjon.ntb.no

· Markus Enzelberger, Chief Scientific Officer of MorphoSys. “While we are clearly disappointed, we remain committed to the development of ...

Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer

finance.yahoo.com

Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific Officer ... A picture of Dr. Markus Enzelberger can be downloaded here.

Markus Enzelberger, Chief Scientific Officer of MorphoSys ...AccessWire

www.accesswire.com

› Ma...

Markus Enzelberger, Chief Scientific Officer of MorphoSys ...NASDAQ

www.nasdaq.com

› marku...

Markus Enzelberger, Chief Scientific Officer of StreetInsiderwww.streetinsider.com › Accesswire › Markus+Enze...

www.streetinsider.com

Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure. November 20, :30 PM. PLANEGG/MUNICH, GERMANY / ACCESSWIRE ...

[PDF] Markus Enzelberger, Chief Scientific Officer of MorphoSys ...n.eqs.com › fncls

n.eqs.com

· MorphoSys AG (FSE: MOR; Prime Standard Segment; MDAX & TecDAX; Nasdaq: MOR) today announced that Dr. Markus Enzelberger, the company's Chief ...

Dr. Markus Enzelberger Appointed MorphoSys's Chief Scientific ...www.morphosys.com › node

www.morphosys.com

· Markus Enzelberger has been appointed as Chief Scientific Officer (CSO), as of November 1, Dr. Enzelberger has been the Company's Interim ...

Baystreet.ca

www.baystreet.ca

Markus Enzelberger, Chief Scientific Officer of MorphoSys, Announces His Departure. [ACCESSWIRE]. PLANEGG/MUNICH, GERMANY ...

USNews - Markus Enzelberger, Chief Scientific Officer of ...www.investingnote.com › posts

www.investingnote.com

... MDAX & TecDAX; NASDAQ:MOR) today announced that Dr. Markus Enzelberger, the company's Chief Scientific Officer (CSO), has decided ...

Acceleration request - SEC.govwww.sec.gov › Archives › edgar › data › filename1

www.sec.gov

/s/ Dr. Markus Enzelberger. By: Dr. Markus Enzelberger. Title: Chief Scientific Officer. /s/ Isabelle Degbegni. By: Isabelle Degbegni. Title: Senior Manager CFCD ...

EdgarFilingSEC.gov

www.sec.gov

... the continuation of the current clinical development of MOR106 in atopic dermatitis” said Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys. › exh_991

MorphoSysPMLiVE

www.pmlive.com

German biotech MorphoSys has appointed Dr Markus Enzelberger as its new chief scientific officer following his predecessor, Dr Marlies Sproll's resignation. › tags

ACROFANus.acrofan.com › detail

us.acrofan.com

... outside of I-Mab's territories after clinical proof of concept," commented Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG.

Mesothelioma Drug Suffers Setback in Clinical MesotheliomaHelpwww.mesotheliomahelp.org › treatment › mesotheli...

www.mesotheliomahelp.org

Markus Enzelberger, Interim Chief Scientific Officer of MorphoSys AG, that partnered with Bayer in the trial, according to a July 21 press release. The main purpose ...

Versant plots Basel expansion as incubator hits full capacityFierceBiotech

www.fiercebiotech.com

Versant has also made a hire to support its third Ridgeline biotech, Bright Peak, recruiting former MorphoSys chief scientific officer Markus Enzelberger to ... › ...

MorphoSys AG (Form: 6-K, Received: :07:45)

www.otcmarkets.com

Dr. Markus Enzelberger, Chief Scientific Officer of MorphoSys AG, said: “We are very pleased that our licensee Janssen has started a pivotal ...

MorphoSys Stops Clinical Development MOR106 In Atopic Dermatitis |...

www.nasdaq.com

· Markus Enzelberger, Chief Scientific Officer of MorphoSys. "While we are clearly disappointed, we remain committed to the development of ...

Peer Review: aTyr promotes data expert Sanjay Shukla as CEO –...

endpts.com

Markus Enzelberger has officially been appointed MorphoSys' (FSE: MOR) chief scientific officer, having served as interim CSO since April. A veteran of the German company, Enzelberger was part of the team that invented HuCAL, the antibody library technology that helped J&J's Janssen develop ...

Alle Infos zum Namen "Markus Enzelberger"

Verwandte Suchanfragen zu Markus Enzelberger

Franz Frei
Marlies Sproll
Otto Himmler

Laura Meier
Andreas Döbel
Till Bachmann

Stefanie Urlinger
Malte Peters
Johannes Kurzweil

Personen
Vorname "Markus" (61377)
Name "Enzelberger" (29)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Markus Enzelberger und Chief Scientific Officer Person-Info